Groundbreaking therapies are reshaping the future of kidney care, offering hope for patients living with CKD and redefining the role of nephrologists in value-based care.
In this episode of Kidney Health Connections, Dr. Katherine Tuttle, a leading nephrologist and researcher, explores the transformative advancements in chronic kidney disease (CKD) treatment. She discusses the revolutionary impact of SGLT2 inhibitors and GLP1 agonists, which have shifted the landscape from modestly effective therapies to groundbreaking treatments that significantly slow disease progression, reduce cardiovascular risks, and even prevent kidney failure. These innovations align seamlessly with value-based care models, offering both clinical and economic benefits.
Dr. Tuttle also highlights the potential of combination therapies and the critical role of implementation in maximizing patient outcomes. As Dr. Tuttle puts it, this is a monumental time in medicine, with the potential to conquer CKD and transform lives.
Tune in to gain practical insights, learn about the emerging wave of new therapies, and discover why early intervention and multidisciplinary collaboration are vital.
You can also watch all episodes of the podcast on our YouTube channel—be sure to subscribe and never miss an update!
Follow Us
Presented by Interwell Health